Anorexia nervosa medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Joseph Nasr, M.D.[2]
Overview
Overview
The primary medical priority in anorexia nervosa is nutritional rehabilitation and weight restoration, particularly in individuals with medical instability. Treatment is best delivered through a multidisciplinary approach, involving physicians, psychiatrists, psychologists, dietitians, and other mental health professionals.[1][2]
Hospitalization is indicated for patients with severe malnutrition, cardiovascular instability, electrolyte abnormalities, or high psychiatric risk. In some cases, involuntary treatment under mental health legislation may be required to prevent life-threatening complications.[1][2]
Nutritional Rehabilitation and Level of Care
Nutritional Rehabilitation and Level of Care
Psychotherapy
Psychotherapy
Psychotherapy is an essential component of treatment and is associated with:
No single psychotherapy modality has demonstrated clear superiority in adults. In adolescents, family-based treatment (Maudsley model) is strongly supported and is associated with sustained improvement.[1]
Pharmacologic Therapy
Pharmacologic Therapy
General Principles
There are no medications with proven efficacy as primary treatment for anorexia nervosa. Pharmacologic therapy plays a limited, adjunctive role and should not replace nutritional rehabilitation or psychotherapy.[1][2]
Antidepressants
- Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants:
- May be considered after partial weight restoration to treat:
Antipsychotic Medications
- Olanzapine may be considered as adjunctive therapy:
- Olanzapine is not effective as monotherapy and should be used selectively
Hormonal Therapy
- Oral estrogen therapy is not recommended:
- Does not improve bone mineral density
- Masks amenorrhea[1]
- Hormonal therapy does not treat anorexia nervosa itself
Cardiac Arrhythmia Risk and Guideline Considerations
Cardiac Arrhythmia Risk and Guideline Considerations
Although earlier cardiology guidelines explicitly addressed anorexia nervosa and severe dieting as risk states for ventricular arrhythmias, more recent ventricular arrhythmia guidelines incorporate these risks under the broader framework of reversible metabolic and systemic causes of arrhythmia. Modern ACC/AHA/HRS and ESC guidelines emphasize correction of underlying abnormalities such as electrolyte disturbances, starvation, bradycardia, and QT prolongation, rather than disease-specific recommendations for eating disorders. Management of life-threatening ventricular arrhythmias in patients with anorexia nervosa follows standard arrhythmia treatment principles, with careful consideration of reversibility, nutritional rehabilitation, and overall prognosis before device implantation.
2006 ACC/AHA/ESC Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death – Obesity, Dieting, and Anorexia (DO NOT EDIT) [6]
| Class I |
| “1. Life-threatening ventricular arrhythmias in patients with obesity, anorexia, or when dieting should be treated in the same manner that such arrhythmias are treated in patients with other diseases, including ICD and pacemaker implantation as required. Patients receiving ICD implantation should be receiving chronic optimal medical therapy and have reasonable expectation of survival with a good functional status for more than 1 y. (Level of Evidence: C) ” |
| Class III |
| “1. Prolonged, unbalanced, very low calorie, semistarvation diets are not recommended; they may be harmful and provoke life-threatening ventricular arrhythmias. (Level of Evidence: C)” |
| Class IIa |
| “1. Programmed weight reduction in obesity and carefully controlled re-feeding in anorexia can effectively reduce the risk of ventricular arrhythmias and SCD. (Level of Evidence: C)” |
References
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 SøebyM, Gribsholt SB, Clausen L, Richelsen B. Fracture risk in patients with anorexia nervosa over a 40-year period. J Bone Miner Res. 2023;38(11): 1586-1593. doi:10.1002/jbmr.4901
- ↑ 2.0 2.1 2.2 2.3 2.4 American Psychiatric Association. Practice Guideline for the Treatment of Patients With Eating Disorders. 4th ed. American Psychiatric Association Publishing; 2023.
- ↑ Solmi M,Wade TD, Byrne S, et al. Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis. Lancet Psychiatry. 2021;8 (3):215-224. doi:10.1016/S2215-0366(20)30566-6
- ↑ 4.0 4.1 Fornaro M, Mondin AM, Billeci M, et al. Psychopharmacology of eating disorders: systematic review and meta-analysis of randomized controlled trials. J Affect Disord. 2023;338:526-545. doi:10.1016/j.jad.2023.06.068
- ↑ Attia E, Steinglass JE,Walsh BT, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry. 2019;176(6):449-456. doi:10.1176/appi. ajp.2018.18101125
- ↑ Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). “ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society”. Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH